SIX1 as a Novel Immunohistochemical Marker in the Differential Diagnosis of Rhabdomyosarcoma

Conclusion: SIX1 immunohistochemistry is positive in most RMS, and occasionally in some tumors within the differential diagnoses of RMS.PMID:37224459 | DOI:10.1080/15513815.2023.2214806

Source: Fetal and Pediatric Pathology - May 24, 2023 Category: Pathology Authors: Daniel Ehinger Hanna Frostberg Sofia Larsson David Gisselsson Source Type: research